Related Experiment Videos
Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes
Magnus Löndahl1, Per Katzman, Anders Nilsson
1Institution for Clinical Sciences in Lund, Lund University, Lund, Sweden. magnus.londahl@med.lu.se
Insights
Hyperbaric oxygen therapy (HBOT) significantly improved healing rates for chronic diabetic foot ulcers compared to placebo. This adjunctive treatment offers a promising solution for difficult-to-heal wounds in diabetic patients.
Area of Science:
- Vascular Surgery
- Diabetology
- Wound Healing
Background:
- Chronic diabetic foot ulcers represent a significant clinical challenge.
- Effective management strategies are crucial to prevent complications and reduce healthcare burden.
Purpose of the Study:
- To evaluate the efficacy of hyperbaric oxygen therapy (HBOT) as an adjunctive treatment for chronic diabetic foot ulcers.
- To compare healing outcomes between HBOT and placebo in a randomized controlled trial.
Main Methods:
- A randomized, single-center, double-blinded, placebo-controlled trial (HODFU study) was conducted.
- Ninety-four patients with chronic diabetic foot ulcers (Wagner grade 2-4) were enrolled.
- Participants received either HBOT or hyperbaric air (placebo) for 85 minutes daily, five days a week, for eight weeks.
Main Results:
- Complete ulcer healing at 1-year follow-up was significantly higher in the HBOT group (52%) compared to the placebo group (29%) (P = 0.03).
- In patients completing over 35 sessions, healing rates were 61% for HBOT versus 27% for placebo (P = 0.009).
- Adverse events were infrequent in both groups.
Conclusions:
- Adjunctive hyperbaric oxygen therapy (HBOT) is effective in facilitating the healing of chronic diabetic foot ulcers in selected patients.
- HBOT represents a valuable therapeutic option for improving outcomes in diabetic wound care.
Objective:
Chronic diabetic foot ulcers are a source of major concern for both patients and health care systems. The aim of this study was to evaluate the effect of hyperbaric oxygen therapy (HBOT) in the management of chronic diabetic foot ulcers.
Research Design And Methods:
The Hyperbaric Oxygen Therapy in Diabetics with Chronic Foot Ulcers (HODFU) study was a randomized, single-center, double-blinded, placebo-controlled clinical trial. The outcomes for the group receiving HBOT were compared with those of the group receiving treatment with hyperbaric air. Treatments were given in a multi-place hyperbaric chamber for 85-min daily (session duration 95 min), five days a week for eight weeks (40 treatment sessions). The study was performed in an ambulatory setting.
Results:
Ninety-four patients with Wagner grade 2, 3, or 4 ulcers, which had been present for >3 months, were studied. In the intention-to-treat analysis, complete healing of the index ulcer was achieved in 37 patients at 1-year of follow-up: 25/48 (52%) in the HBOT group and 12/42 (29%) in the placebo group (P = 0.03). In a sub-analysis of those patients completing >35 HBOT sessions, healing of the index ulcer occurred in 23/38 (61%) in the HBOT group and 10/37 (27%) in the placebo group (P = 0.009). The frequency of adverse events was low.
Conclusions:
The HODFU study showed that adjunctive treatment with HBOT facilitates healing of chronic foot ulcers in selected patients with diabetes.
Related Concept Videos
Diabetic Foot Ulcer
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation